{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38361765", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "19"}, "Article": {"Language": ["eng"], "ELocationID": ["5573353", "10.1155/2024/5573353"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "08"}], "Journal": {"ISSN": "1466-1861", "JournalIssue": {"Volume": "2024", "PubDate": {"Year": "2024"}}, "Title": "Mediators of inflammation", "ISOAbbreviation": "Mediators Inflamm"}, "ArticleTitle": "Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats.", "Pagination": {"StartPage": "5573353", "MedlinePgn": "5573353"}, "Abstract": {"AbstractText": ["As an interstitial fibrosis disease characterized by diffuse alveolitis and structural alveolar disorders, idiopathic pulmonary fibrosis (IPF) has high lethality but lacks limited therapeutic drugs. A hospital preparation used for the treatment of viral pneumonia, Qingfei Tongluo mixture (QFTL), is rumored to have protective effects against inflammatory and respiratory disease. This study aims to confirm whether it has a therapeutic effect on bleomycin-induced IPF in rats and to elucidate its mechanism of action. Male SD rats were randomly divided into the following groups: control, model, CQ\u2009+\u2009QFTL (84\u2009mg/kg chloroquine (CQ)\u2009+\u20093.64\u2009g/kg QFTL), QFTL-L, M, H (3.64, 7.28, and 14.56\u2009g/kg, respectively) and pirfenidone (PFD 420\u2009mg/kg). After induction modeling and drug intervention, blood samples and lung tissue were collected for further detection. Body weight and lung coefficient were examined, combined with hematoxylin and eosin (H&E) and Masson staining to observe lung tissue lesions. The enzyme-linked immunosorbent assay (ELISA) and the hydroxyproline (HYP) assay kit were used to detect changes in proinflammatory factors (transforming growth factor-<i>\u03b2</i> (TGF-<i>\u03b2</i>), tumor necrosis factor-<i>\u03b1</i> (TNF-<i>\u03b1</i>), and interleukin-1<i>\u03b2</i> (IL-1<i>\u03b2</i>)) and HYP. Immunohistochemistry and Western blotting were performed to observe changes in proteins related to pulmonary fibrosis (<i>\u03b1</i>-smooth muscle actin (<i>\u03b1</i>-SMA) and matrix metalloproteinase 12 (MMP12)) and autophagy (P62 and mechanistic target of rapamycin (mTOR)). Treatment with QFTL significantly improved the adverse effects of bleomycin on body weight, lung coefficient, and pathological changes. Then, QFTL reduced bleomycin-induced increases in proinflammatory mediators and HYP. The expression changes of pulmonary fibrosis and autophagy marker proteins are attenuated by QFTL. Furthermore, the autophagy inhibitor CQ significantly reversed the downward trend in HYP levels and <i>\u03b1</i>-SMA protein expression, which QFTL improved in BLM-induced pulmonary fibrosis rats. In conclusion, QFTL could effectively attenuate bleomycin-induced inflammation and pulmonary fibrosis through mTOR-dependent autophagy in rats. Therefore, QFTL has the potential to be an alternative treatment for IPF in clinical practice."], "CopyrightInformation": "Copyright \u00a9 2024 Shuyu Ge et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China."}], "LastName": "Ge", "ForeName": "Shuyu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China."}], "LastName": "Guo", "ForeName": "Zhenghong", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550031, China."}], "LastName": "Xiao", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China."}], "LastName": "Sun", "ForeName": "Pingping", "Initials": "P"}, {"Identifier": ["0000-0002-1572-9764"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China."}], "LastName": "Yang", "ForeName": "Bo", "Initials": "B"}, {"Identifier": ["0000-0003-4767-0602"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China."}], "LastName": "Ying", "ForeName": "Yin", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Mediators Inflamm", "NlmUniqueID": "9209001", "ISSNLinking": "0962-9351"}, "ChemicalList": [{"RegistryNumber": "11056-06-7", "NameOfSubstance": "Bleomycin"}, {"RegistryNumber": "0", "NameOfSubstance": "qingfei tongluo"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "EC 2.7.1.1", "NameOfSubstance": "mTOR protein, rat"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Pulmonary Fibrosis"}, {"QualifierName": ["toxicity"], "DescriptorName": "Bleomycin"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lung"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Pneumonia"}, {"QualifierName": ["pharmacology"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": [], "DescriptorName": "Body Weight"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transforming Growth Factor beta1"}, {"QualifierName": [], "DescriptorName": "Drugs, Chinese Herbal"}], "CoiStatement": "All authors declared that there are no conflicts of interest in this experiment."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Moss B. J., Ryter S. W., Rosas I. O. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annual Review of Pathology: Mechanisms of Disease . 2022;17(1):515\u2013546. doi: 10.1146/annurev-pathol-042320-030240.", "ArticleIdList": ["10.1146/annurev-pathol-042320-030240", "34813355"]}, {"Citation": "Hewlett J. C., Kropski J. A., Blackwell T. S. Idiopathic pulmonary fibrosis: epithelial\u2013mesenchymal interactions and emerging therapeutic targets. Matrix Biology . 2018;71-72:112\u2013127. doi: 10.1016/j.matbio.2018.03.021.", "ArticleIdList": ["10.1016/j.matbio.2018.03.021", "PMC6146058", "29625182"]}, {"Citation": "Ding Y., Hou Y., Liu Y., Yu T., Cui Y., Nie H. MiR-130a-3p alleviates inflammatory and fibrotic phases of pulmonary fibrosis through proinflammatory factor TNF-\u03b1 and profibrogenic receptor TGF-\u03b2RII. Frontiers in Pharmacology . 2022;13 doi: 10.3389/fphar.2022.863646.863646", "ArticleIdList": ["10.3389/fphar.2022.863646", "PMC9006815", "35431964"]}, {"Citation": "Li S.-X., Li C., Pang X.-R., et al. Metformin attenuates silica-induced pulmonary fibrosis by activating autophagy via the AMPK-mTOR signaling pathway. Frontiers in Pharmacology . 2021;12 doi: 10.3389/fphar.2021.719589.719589", "ArticleIdList": ["10.3389/fphar.2021.719589", "PMC8381252", "34434111"]}, {"Citation": "Li X., Wang Y., Liang J., et al. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-\u03b21 signaling pathway. Phytotherapy Research . 2021;35(10):5808\u20135822. doi: 10.1002/ptr.7239.", "ArticleIdList": ["10.1002/ptr.7239", "34375009"]}, {"Citation": "Komi D. E. A., Khomtchouk K., Santa Maria P. L. A review of the contribution of mast cells in wound healing: involved molecular and cellular mechanisms. Clinical Reviews in Allergy & Immunology . 2020;58(3):298\u2013312. doi: 10.1007/s12016-019-08729-w.", "ArticleIdList": ["10.1007/s12016-019-08729-w", "30729428"]}, {"Citation": "Cabrera S., Maciel M., Herrera I., et al. Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis. Autophagy . 2015;11(4):670\u2013684. doi: 10.1080/15548627.2015.1034409.", "ArticleIdList": ["10.1080/15548627.2015.1034409", "PMC4502665", "25906080"]}, {"Citation": "Lv X., Li K., Hu Z. Autophagy and pulmonary fibrosis. In: Le W., editor. Autophagy: Biology and Diseases . Vol. 1207. Singapore: Springer; 2020. pp. 569\u2013579. (Advances in Experimental Medicine and Biology).", "ArticleIdList": ["10.1007/978-981-15-4272-5_40", "32671775"]}, {"Citation": "Alsayed H. A., Mohammad H. M. F., Khalil C. M., El-Kherbetawy M. K., Elaidy S. M. Autophagy modulation by irbesartan mitigates the pulmonary fibrotic alterations in bleomycin challenged rats: comparative study with rapamycin. Life Sciences . 2022;303 doi: 10.1016/j.lfs.2022.120662.120662", "ArticleIdList": ["10.1016/j.lfs.2022.120662", "35636582"]}, {"Citation": "Gupta S. S., Zeglinski M. R., Rattan S. G., et al. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts. Oncotarget . 2016;7(48):78516\u201378531. doi: 10.18632/oncotarget.12392.", "ArticleIdList": ["10.18632/oncotarget.12392", "PMC5346657", "27705938"]}, {"Citation": "Hern\u00e1ndez\u2013Gea V., Ghiassi\u2013Nejad Z., Rozenfeld R., et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology . 2012;142(4):938\u2013946. doi: 10.1053/j.gastro.2011.12.044.", "ArticleIdList": ["10.1053/j.gastro.2011.12.044", "PMC3439519", "22240484"]}, {"Citation": "Wang H., Liu Y., Wang D., et al. The upstream pathway of mTOR-mediated autophagy in liver diseases. Cells . 2019;8(12) doi: 10.3390/cells8121597.1597", "ArticleIdList": ["10.3390/cells8121597", "PMC6953127", "31835352"]}, {"Citation": "Kim Y. C., Guan K.-L. mTOR: a pharmacologic target for autophagy regulation. Journal of Clinical Investigation . 2015;125(1):25\u201332. doi: 10.1172/JCI73939.", "ArticleIdList": ["10.1172/JCI73939", "PMC4382265", "25654547"]}, {"Citation": "Liu Y.-M., Nepali K., Liou J.-P. Idiopathic pulmonary fibrosis: current status, recent progress, and emerging targets. Journal of Medicinal Chemistry . 2017;60(2):527\u2013553. doi: 10.1021/acs.jmedchem.6b00935.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00935", "28122457"]}, {"Citation": "Pasquier B. Autophagy inhibitors. Cellular and Molecular Life Sciences . 2016;73(5):985\u20131001. doi: 10.1007/s00018-015-2104-y.", "ArticleIdList": ["10.1007/s00018-015-2104-y", "26658914"]}, {"Citation": "Yu J.-Z., Ying Y., Liu Y., et al. Antifibrotic action of Yifei Sanjie formula enhanced autophagy via PI3K-AKT-mTOR signaling pathway in mouse model of pulmonary fibrosis. Biomedicine & Pharmacotherapy . 2019;118 doi: 10.1016/j.biopha.2019.109293.109293", "ArticleIdList": ["10.1016/j.biopha.2019.109293", "31401393"]}, {"Citation": "Gui Y.-S., Wang L., Tian X., et al. mTOR overactivation and compromised autophagy in the pathogenesis of pulmonary fibrosis. PLOS ONE . 2015;10(9) doi: 10.1371/journal.pone.0138625.e0138625", "ArticleIdList": ["10.1371/journal.pone.0138625", "PMC4575195", "26382847"]}, {"Citation": "Fu J., Lu L., Wang H., Hou Y., Dou H. Hirsutella sinensis mycelium regulates autophagy of alveolar macrophages via TLR4/NF-\u03baB signaling pathway. International Journal of Medical Sciences . 2021;18(8):1810\u20131823. doi: 10.7150/ijms.51654.", "ArticleIdList": ["10.7150/ijms.51654", "PMC7976595", "33746598"]}, {"Citation": "Myll\u00e4rniemi M., Kaarteenaho R. Pharmacological treatment of idiopathic pulmonary fibrosis\u2013preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine. European Clinical Respiratory Journal . 2015;2(1) doi: 10.3402/ecrj.v2.26385.26385", "ArticleIdList": ["10.3402/ecrj.v2.26385", "PMC4629756", "26557253"]}, {"Citation": "Xu L., Jing M., Yang L., et al. The Alisma and Rhizoma decoction abates nonalcoholic steatohepatitis-associated liver injuries in mice by modulating oxidative stress and autophagy. BMC Complementary and Alternative Medicine . 2019;19(1) doi: 10.1186/s12906-019-2488-6.92", "ArticleIdList": ["10.1186/s12906-019-2488-6", "PMC6489313", "31035991"]}, {"Citation": "Ge M., Liu H., Zhang Y., et al. The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. British Journal of Pharmacology . 2017;174(10):1147\u20131160. doi: 10.1111/bph.13766.", "ArticleIdList": ["10.1111/bph.13766", "PMC5406384", "28257144"]}, {"Citation": "He Y., Lu R., Wu J., et al. Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy. Biomedicine & Pharmacotherapy . 2020;128 doi: 10.1016/j.biopha.2020.110241.110241", "ArticleIdList": ["10.1016/j.biopha.2020.110241", "32450523"]}, {"Citation": "Yan S., Yue Y.-Z., Sun M.-M., Wu B.-S., Wang X.-P. Suppressive effect of aurantii fructus immaturus and atractylodis macrocephalae rhizoma on glutamic acid-induced autophagy of interstitial cells of cajal. Journal of Integrative Medicine . 2020;18(4):334\u2013343. doi: 10.1016/j.joim.2020.04.005.", "ArticleIdList": ["10.1016/j.joim.2020.04.005", "32532614"]}, {"Citation": "Xu Z., Jiang H., Zhu Y., et al. Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cells. Chemico-Biological Interactions . 2017;273:48\u201355. doi: 10.1016/j.cbi.2017.06.003.", "ArticleIdList": ["10.1016/j.cbi.2017.06.003", "28600121"]}, {"Citation": "Hao W., Zhang X., Zhao W., et al. Cryptotanshinone induces pro-death autophagy through JNK signaling mediated by reactive oxygen species generation in lung cancer cells. Anti-Cancer Agents in Medicinal Chemistry . 2016;16(5):593\u2013600. doi: 10.2174/1871520615666150907093036.", "ArticleIdList": ["10.2174/1871520615666150907093036", "26343144"]}, {"Citation": "Pan Y., Chen L., Li R., Liu Y., Nan M., Hou L. Tanshinone iia induces autophagy and apoptosis via PI3K/Akt/mTOR axis in acute promyelocytic leukemia NB4 cells. Evidence-Based Complementary and Alternative Medicine . 2021;2021:9. doi: 10.1155/2021/3372403.3372403", "ArticleIdList": ["10.1155/2021/3372403", "PMC8536410", "34691211"]}, {"Citation": "Park S.-H., Chi G. Y., Eom H. S., et al. Role of autophagy in apoptosis induction by methylene chloride extracts of Mori cortex in NCI-H460 human lung carcinoma cells. International Journal of Oncology . 2012;40(6):1929\u20131940. doi: 10.3892/ijo.2012.1386.", "ArticleIdList": ["10.3892/ijo.2012.1386", "22367066"]}, {"Citation": "L\u00ea H.-G., Choi J.-S., Hwang B.-S., et al. Phragmites australis (Cav.) trin. ex steud. extract induces apoptosis-like programmed cell death in Acanthamoeba castellanii trophozoites. Plants . 2022;11(24) doi: 10.3390/plants11243459.3459", "ArticleIdList": ["10.3390/plants11243459", "PMC9783201", "36559571"]}, {"Citation": "Yim N.\u2013H., Hwang Y.\u2013H., Liang C., Ma J. Y. A platycoside-rich fraction from the root of Platycodon grandiflorum enhances cell death in A549 human lung carcinoma cells via mainly AMPK/mTOR/AKT signal-mediated autophagy induction. Journal of Ethnopharmacology . 2016;194:1060\u20131068. doi: 10.1016/j.jep.2016.10.078.", "ArticleIdList": ["10.1016/j.jep.2016.10.078", "27989873"]}, {"Citation": "Du Z., Wang Q., Ma G., et al. Inhibition of Nrf2 promotes the antitumor effect of Pinelliae rhizome in papillary thyroid cancer. Journal of Cellular Physiology . 2019;234(8):13867\u201313877. doi: 10.1002/jcp.28069.", "ArticleIdList": ["10.1002/jcp.28069", "30697724"]}, {"Citation": "Yang G., Li J., Cai Y., Yang Z., Li R., Fu W. Glycyrrhizic acid alleviates 6-hydroxydopamine and corticosterone-induced neurotoxicity in SH-SY5Y cells through modulating autophagy. Neurochemical Research . 2018;43(10):1914\u20131926. doi: 10.1007/s11064-018-2609-5.", "ArticleIdList": ["10.1007/s11064-018-2609-5", "30206804"]}, {"Citation": "Della Latta V., Cecchettini A., Del Ry S., Morales M. A. Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacological Research . 2015;97:122\u2013130. doi: 10.1016/j.phrs.2015.04.012.", "ArticleIdList": ["10.1016/j.phrs.2015.04.012", "25959210"]}, {"Citation": "Chen J., Lu J., Wang B., et al. Polysaccharides from Dendrobium officinale inhibit bleomycin-induced pulmonary fibrosis via the TGF\u03b21-Smad2/3 axis. International Journal of Biological Macromolecules . 2018;118:2163\u20132175. doi: 10.1016/j.ijbiomac.2018.07.056.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.07.056", "30030077"]}, {"Citation": "Nie J., Liu Y., Sun C., et al. Effect of supercritical carbon dioxide fluid extract from Chrysanthemum indicum Linn\u00e9 on bleomycin-induced pulmonary fibrosis. BMC Complementary Medicine and Therapies . 2021;21(1) doi: 10.1186/s12906-021-03409-9.240", "ArticleIdList": ["10.1186/s12906-021-03409-9", "PMC8464116", "34563177"]}, {"Citation": "Yang J., Shi X., Gao R., et al. Polydatin alleviates bleomycin-induced pulmonary fibrosis and alters the gut microbiota in a mouse model. Journal of Cellular and Molecular Medicine . 2023;27(23):3717\u20133728. doi: 10.1111/jcmm.17937.", "ArticleIdList": ["10.1111/jcmm.17937", "PMC10718135", "37665061"]}, {"Citation": "Xie Y., Jiang H., Zhang Q., et al. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis. Respiratory Research . 2016;17(1) doi: 10.1186/s12931-016-0418-4.103", "ArticleIdList": ["10.1186/s12931-016-0418-4", "PMC4994235", "27549302"]}, {"Citation": "Du S., Li C., Lu Y., et al. Dioscin alleviates crystalline silica-induced pulmonary inflammation and fibrosis through promoting alveolar macrophage autophagy. Theranostics . 2019;9(7):1878\u20131892. doi: 10.7150/thno.29682.", "ArticleIdList": ["10.7150/thno.29682", "PMC6485284", "31037145"]}, {"Citation": "Geng F., Xu M., Zhao L., et al. Quercetin alleviates pulmonary fibrosis in mice exposed to silica by inhibiting macrophage senescence. Frontiers in Pharmacology . 2022;13 doi: 10.3389/fphar.2022.912029.912029", "ArticleIdList": ["10.3389/fphar.2022.912029", "PMC9360590", "35959439"]}, {"Citation": "Mo X., Jian W., Su Z., et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal . 2020;55(6) doi: 10.1183/13993003.01217-2020.2001217", "ArticleIdList": ["10.1183/13993003.01217-2020", "PMC7236826", "32381497"]}, {"Citation": "George P. M., Wells A. U., Jenkins R. G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. The Lancet Respiratory Medicine . 2020;8(8):807\u2013815. doi: 10.1016/S2213-2600(20)30225-3.", "ArticleIdList": ["10.1016/S2213-2600(20)30225-3", "PMC7228727", "32422178"]}, {"Citation": "Jenkins R. G., Moore B. B., Chambers R. C., et al. An official american thoracic society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. American Journal of Respiratory Cell and Molecular Biology . 2017;56(5):667\u2013679. doi: 10.1165/rcmb.2017-0096ST.", "ArticleIdList": ["10.1165/rcmb.2017-0096ST", "PMC5800895", "28459387"]}, {"Citation": "B. Moore B., Lawson W. E., Oury T. D., Sisson T. H., Raghavendran K., Hogaboam C. M. Animal models of fibrotic lung disease. American Journal of Respiratory Cell and Molecular Biology . 2013;49(2):167\u2013179. doi: 10.1165/rcmb.2013-0094TR.", "ArticleIdList": ["10.1165/rcmb.2013-0094TR", "PMC3824038", "23526222"]}, {"Citation": "Collins S. L., Chan-Li Y., Oh M. H., et al. Vaccinia vaccine\u2013based immunotherapy arrests and reverses established pulmonary fibrosis. JCI Insight . 2016;1(4) doi: 10.1172/jci.insight.83116.e83116", "ArticleIdList": ["10.1172/jci.insight.83116", "PMC4855513", "27158671"]}, {"Citation": "Degryse A. L., Tanjore H., Xu X. C., et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology . 2010;299(4):L442\u2013L452. doi: 10.1152/ajplung.00026.2010.", "ArticleIdList": ["10.1152/ajplung.00026.2010", "PMC2957416", "20562227"]}, {"Citation": "Wang Y., Hu S., Shen L., et al. Dynamic observation of autophagy and transcriptome profiles in a mouse model of bleomycin-induced pulmonary fibrosis. Frontiers in Molecular Biosciences . 2021;8 doi: 10.3389/fmolb.2021.664913.664913", "ArticleIdList": ["10.3389/fmolb.2021.664913", "PMC8358296", "34395518"]}, {"Citation": "Abbas N. A. T., Nafea O. E., Mohammed H. O., et al. Repurposing of carvedilol to alleviate bleomycin-induced lung fibrosis in rats: repressing of TGF-\u03b21/\u03b1-SMA/Smad2/3 and STAT3 gene expressions. Life Sciences . 2023;324 doi: 10.1016/j.lfs.2023.121692.121692", "ArticleIdList": ["10.1016/j.lfs.2023.121692", "37061127"]}, {"Citation": "Albanawany N. M., Samy D. M., Zahran N., El-Moslemany R. M., Elsawy S. M., Abou Nazel M. W. Histopathological, physiological and biochemical assessment of resveratrol nanocapsules efficacy in bleomycin-induced acute and chronic lung injury in rats. Drug Delivery . 2022;29(1):2592\u20132608. doi: 10.1080/10717544.2022.2105445.", "ArticleIdList": ["10.1080/10717544.2022.2105445", "PMC9373765", "35945895"]}, {"Citation": "Kim S. N., Lee J., Yang H.-S., et al. Dose-response effects of bleomycin on inflammation and pulmonary fibrosis in mice. Toxicological Research . 2010;26:217\u2013222. doi: 10.5487/TR.2010.26.3.217.", "ArticleIdList": ["10.5487/TR.2010.26.3.217", "PMC3834487", "24278527"]}, {"Citation": "Nie Y., Yu K., Li B., et al. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-\u03baB signaling pathway in mice. Journal of Pharmacological Sciences . 2019;139(4):377\u2013384. doi: 10.1016/j.jphs.2019.03.002.", "ArticleIdList": ["10.1016/j.jphs.2019.03.002", "30928090"]}, {"Citation": "Sun Q., Hu J., Yu P., et al. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-\u03b2/smad signaling pathway. Experimental Lung Research . 2019;45(5-6):123\u2013134. doi: 10.1080/01902148.2019.1614696.", "ArticleIdList": ["10.1080/01902148.2019.1614696", "31210057"]}, {"Citation": "Xu J., Li W., Xu S., Gao W., Yu Z. Effect of dermatan sulphate on a C57-mouse model of pulmonary fibrosis. Journal of International Medical Research . 2019;47(6):2655\u20132665. doi: 10.1177/0300060519842048.", "ArticleIdList": ["10.1177/0300060519842048", "PMC6567691", "31006321"]}, {"Citation": "Peyser R., MacDonnell S., Gao Y., et al. Defining the activated fibroblast population in lung fibrosis using single-cell sequencing. American Journal of Respiratory Cell and Molecular Biology . 2019;61(1):74\u201385. doi: 10.1165/rcmb.2018-0313OC.", "ArticleIdList": ["10.1165/rcmb.2018-0313OC", "30848683"]}, {"Citation": "Liu M., Sun H., Wang X., et al. Association of increased expression of macrophage elastase (matrix metalloproteinase 12) with rheumatoid arthritis. Arthritis & Rheumatism . 2004;50(10):3112\u20133117. doi: 10.1002/art.20567.", "ArticleIdList": ["10.1002/art.20567", "15476203"]}, {"Citation": "Ehrentraut S. F., Kominsky D. J., Glover L. E., et al. Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response. The Journal of Immunology . 2013;190(1):392\u2013400. doi: 10.4049/jimmunol.1202041.", "ArticleIdList": ["10.4049/jimmunol.1202041", "PMC3529810", "23209320"]}, {"Citation": "Savin I. A., Zenkova M. A., Sen\u2019kova A. V. Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. International Journal of Molecular Sciences . 2022;23(23) doi: 10.3390/ijms232314959.14959", "ArticleIdList": ["10.3390/ijms232314959", "PMC9735580", "36499287"]}, {"Citation": "Meng X.-M., Nikolic-Paterson D. J., Lan H. Y. TGF-\u03b2: the master regulator of fibrosis. Nature Reviews Nephrology . 2016;12(6):325\u2013338. doi: 10.1038/nrneph.2016.48.", "ArticleIdList": ["10.1038/nrneph.2016.48", "27108839"]}, {"Citation": "Guo J., Luo Y., Yin F., et al. Overexpression of tumor necrosis factor-like ligand 1 A in myeloid cells aggravates liver fibrosis in mice. Journal of Immunology Research . 2019;2019:15. doi: 10.1155/2019/7657294.7657294", "ArticleIdList": ["10.1155/2019/7657294", "PMC6393882", "30906791"]}, {"Citation": "Hoshino T., Okamoto M., Sakazaki Y., Kato S., Young H. A., Aizawa H. Role of proinflammatory cytokines IL-18 and IL-1\u03b2 in bleomycin-induced lung injury in humans and mice. American Journal of Respiratory Cell and Molecular Biology . 2009;41(6):661\u2013670. doi: 10.1165/rcmb.2008-0182OC.", "ArticleIdList": ["10.1165/rcmb.2008-0182OC", "PMC10283344", "19265174"]}, {"Citation": "Glick D., Barth S., Macleod K. F. Autophagy: cellular and molecular mechanisms. The Journal of Pathology . 2010;221(1):3\u201312. doi: 10.1002/path.2697.", "ArticleIdList": ["10.1002/path.2697", "PMC2990190", "20225336"]}, {"Citation": "Mizushima N. Autophagy: process and function. Genes & Development . 2007;21(22):2861\u20132873. doi: 10.1101/gad.1599207.", "ArticleIdList": ["10.1101/gad.1599207", "18006683"]}, {"Citation": "Turco E., Savova A., Gere F., et al. Reconstitution defines the roles of p62, NBR1 and TAX1BP1 in ubiquitin condensate formation and autophagy initiation. Nature Communications . 2021;12(1) doi: 10.1038/s41467-021-25572-w.", "ArticleIdList": ["10.1038/s41467-021-25572-w", "PMC8410870", "34471133"]}, {"Citation": "Liu M.-W., Su M.-X., Tang D.-Y., Hao L., Xun X.-H., Huang Y.-Q. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression. BMC Pulmonary Medicine . 2019;19(1) doi: 10.1186/s12890-019-0799-5.35", "ArticleIdList": ["10.1186/s12890-019-0799-5", "PMC6371511", "30744607"]}, {"Citation": "Zhang X., Su J., Lin J., et al. Fu-Zheng-Tong-Luo formula promotes autophagy and alleviates idiopathic pulmonary fibrosis by controlling the Janus kinase 2/signal transducer and activator of transcription 3 pathway. Journal of Ethnopharmacology . 2023;314 doi: 10.1016/j.jep.2023.116633.116633", "ArticleIdList": ["10.1016/j.jep.2023.116633", "37207878"]}, {"Citation": "Liu H., Pang Q., Cao F., et al. Number 2 feibi recipe ameliorates pulmonary fibrosis by inducing autophagy through the GSK-3\u03b2/mTOR pathway. Frontiers in Pharmacology . 2022;13 doi: 10.3389/fphar.2022.921209.921209", "ArticleIdList": ["10.3389/fphar.2022.921209", "PMC9315309", "35903328"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "2"}, {"Year": "2024", "Month": "1", "Day": "24"}, {"Year": "2024", "Month": "1", "Day": "27"}, {"Year": "2024", "Month": "2", "Day": "19", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "16", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "16", "Hour": "3", "Minute": "47"}, {"Year": "2024", "Month": "2", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["38361765", "PMC10869187", "10.1155/2024/5573353"]}}]}